A Study of RAY1225 in Participants With Type 2 Diabetes
Conditions: T2DM (Type 2 Diabetes Mellitus) Interventions: Drug: RAY1225; Drug: Placebo Sponsors: Guangdong Raynovent Biotech Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Research | Study